摘要
目的观察并探讨阿卡波糖与二甲双胍治疗糖尿病合并高脂血症的效果。方法以该院2017年10月—2019年10月就诊的94例糖尿病合并高脂血症患者为对象,分为对照组及研究组,每组47例。前者进行单一二甲双胍治疗,后者进行此基础上的阿卡波糖联合治疗,分析两组治疗前后的血糖水平以及血脂水平,评定治疗有效率。结果治疗前,两组患者血糖、血脂水平差异无统计学意义(P>0.05);经过治疗,研究组血糖水平以及血脂水平与对照组相比差异有统计学意义(P<0.05);研究组患者治疗有效率为95.75%,明显高于对照组的80.85%,差异有统计学意义(P<0.05)。结论在糖尿病合并高脂血症患者临床治疗中应用阿卡波糖联合二甲双胍治疗效果更佳,相较于单一二甲双胍治疗,在改善血糖、血脂水平方面明显更为理想,且安全性较高,不易发生不良反应。
Objective To observe and discuss the effects of acarbose and metformin in the treatment of diabetes with hyperlipidemia.Methods The 94 patients with diabetes and hyperlipidemia who were treated in the hospital from October 2017 to October 2019 were divided into a control group and a study group,with 47 cases in each group.The former received single metformin treatment,and the latter performed this basis.Acarbose combination treatment on the previous page,analyze the blood glucose levels and blood lipid levels of the two groups before and after treatment,and evaluate the treatment efficiency.Results Before treatment,there was no statistically significant difference in blood glucose and blood lipid levels between the two groups of patients(P>0.05).After treatment,the blood glucose Levels and blood lipid levels of the study group were significantly difference from those of the control group,the difference was statistically significant(P<0.05);the effective rate of treatment in the study group was 95.75%,which was significantly higher 80.85%of the control group,the difference was statistically significant(P<0.05).Conclusion Acarbose combined with metformin is more effective in the clinical treatment of patients with diabetes and hyperlipidemia.Compared with single metformin treatment,it is significantly more ideal in improving blood glucose and blood lipid levels,and it is safer and unlikely to have the occurrence of adverse reactions.
作者
邢质君
XING Zhi-jun(Department of Pharmacy,the First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui Province,233000 China)
出处
《糖尿病新世界》
2020年第22期78-80,共3页
Diabetes New World Magazine
